Bausch Health Companies | VRX - Zinsaufwendungen Für Schuld

Aktienkurs
7.51
Täglich Wechseln
0.03 0.33%
Monatlich
3.52%
Jährlich
0.60%
Q2 Prognose
7.29




Zinsaufwendungen Für Schuld Veränderung Datum
Amgen USD 653M 32M 2025-12
ANI Pharmaceuticals USD 4.41M 316K 2025-12
Aurora Cannabis CAD 2.11M 116K 2025-12
Bausch Health Companies USD 412M 53M 2025-09
Biogen USD 72.6M 12.6M 2025-06
Bristol-Myers Squibb USD 432M 48M 2025-12
Canopy Growth CAD 7.34M 1.46M 2025-12
Corcept Therapeutics USD 823.61M 21.88M 2025-09
Danaher USD 55M 12M 2025-12
Drreddys Laboratories INR 944M 127M 2025-12
Eli Lilly USD 114.7M 134.3M 2025-09
Gilead Sciences USD 255M 1000K 2025-12
Nektar Therapeutics USD 9.77M 3.75M 2025-12
Novo Nordisk DKK 1.53B 3.43B 2025-09
Pacira USD 3.89M 387K 2025-12
Perrigo USD 10.08B 10.04B 2025-09
Phibro Animal Health USD 11.91M 191K 2025-12
Prestige Brands USD 10.67M 636K 2025-12
Supernus Pharmaceuticals USD 910K 278K 2023-06
Vertex Pharmaceuticals USD 3.3M 0 2025-12
Zoetis USD 57M 1000K 2025-12